Download Free Sample Report

CMO & CDMO Market, Global Outlook and Forecast 2023-2032

CMO & CDMO Market, Global Outlook and Forecast 2023-2032

  • Published on : 28 September 2023
  • Pages :69
  • Report Code:SMR-7820314

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global CMO & CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro
This report aims to provide a comprehensive presentation of the global market for CMO & CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO & CDMO. This report contains market size and forecasts of CMO & CDMO in global, including the following market information:

  • Global CMO & CDMO Market Revenue, 2018-2023, 2024-2032, ($ millions)
  • Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Development Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CMO & CDMO include Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun and Piramal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CMO & CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CMO & CDMO Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global CMO & CDMO Market Segment Percentages, by Type, 2022 (%)

  • Development
  • API production
  • Formulation

Global CMO & CDMO Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global CMO & CDMO Market Segment Percentages, by Application, 2022 (%)

  • Pharmaceutical Industry
  • Biotechnology
  • Other

Global CMO & CDMO Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global CMO & CDMO Market Segment Percentages, By Region and Country, 2022 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies CMO & CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies CMO & CDMO revenues share in global market, 2022 (%)

Key players include:

  • Recipharm
  • AMRI3
  • Patheon
  • Aenova
  • Catalent
  • Amatsigroup
  • WuXi PharmaTech
  • Strides Shasun
  • Piramal
  • Siegfried

Outline of Major Chapters:
Chapter 1: Introduces the definition of CMO & CDMO, market overview.
Chapter 2: Global CMO & CDMO market size in revenue.
Chapter 3: Detailed analysis of CMO & CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CMO & CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.